| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.25 | 5e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |